Previous 10 |
home / stock / ucbjy / ucbjy news
BRUSSELS , June 14, 2019 /PRNewswire/ -- UCB, a global biopharmaceutical company, announced new Phase 2b data on the company's key pipeline molecule, bimekizumab – a novel humanized monoclonal IgG1 antibody that potently and selectively neutralizes both IL-17A and IL-17F ...
BRUSSELS and ATLANTA , May 20, 2019 /PRNewswire/ -- UCB announced today that the U.S. Food and Drug Administration (FDA) has approved a New Drug Application for the company's newest anti-epileptic drug (AED) NAYZILAM ® (midazolam) nasal spray CIV, a benzodiazepine indicated f...
THOUSAND OAKS, Calif. and BRUSSELS , April 9, 2019 /PRNewswire/ -- Amgen (NASDAQ: AMGN) and UCB (Euronext Brussels: UCB) today announced that the U.S. Food and Drug Administration (FDA) has approved EVENITY™ (romosozumab-aqqg) for the treatment of osteoporosis in postmenopau...
BRUSSELS , March 28, 2019 /PRNewswire/ -- UCB, a global biopharmaceutical company, announced today that the U.S. Food and Drug Administration (FDA) has approved extending the label for CIMZIA ® (certolizumab pegol) to include a new indication for the treatment of adul...
- 80 to 100% of BE ABLE 1 responders maintained a response of at least 90% disease improvement (PASI90) over 60 weeks with bimekizumab - These positive results mark the longest-term data to date demonstrating durable PASI90/PASI100 outcomes to 60 weeks with investigational molecule bi...
Late breaking presentation of the Phase 2b long-term findings on the investigational molecule, bimekizumab, demonstrates complete or almost complete skin clearance in moderate-to-severe plaque psoriasis Long-term data from Phase 3 studies CIMPASI-1, CIMPASI-2 and CIMPACT highlight the s...
Background Amgen ( AMGN ) has the same sort of problem that two of my somewhat struggling biotech longs have: old blockbusters with biosimilar threats. (These are AbbVie ( ABBV ) and Roche ( RHHBY ).) For that reason, even though I have not traded AMGN in almost two years, when I sold out at...
News, Short Squeeze, Breakout and More Instantly...
UCB S.A. ADR Company Name:
UCBJY Stock Symbol:
OTCMKTS Market:
UCB partners with Emmy Award winner Ben Decter and Tony Award nominee Kristin Hanggi in their heartfelt musical about living with epilepsy: It's All Your Fault, Tyler Price! PR Newswire Emmy Award winner Ben Decter and Tony Award nominee Kristin Hanggi announce the fu...
FINTEPLA® (fenfluramine) Results Examining its Impact in Managing Generalized Tonic-Clonic Seizures in Developmental and Epileptic Encephalopathies Published in Epilepsia PR Newswire FINTEPLA is approved by the U.S. Food and Drug Administration (FDA) for the treatment of ...
New CIMZIA® data for women living with chronic rheumatic diseases throughout pregnancy, and for people living with RA and high rheumatoid factor levels PR Newswire Pharmacokinetic data from the CHERISH study suggest that pregnant women treated with certolizumab pegol can ...